1n2r

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1n2r" size="450" color="white" frame="true" align="right" spinBox="true" caption="1n2r, resolution 1.7&Aring;" /> '''A natural selected d...)
Line 1: Line 1:
-
[[Image:1n2r.gif|left|200px]]<br />
+
[[Image:1n2r.jpg|left|200px]]<br /><applet load="1n2r" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1n2r" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1n2r, resolution 1.7&Aring;" />
caption="1n2r, resolution 1.7&Aring;" />
'''A natural selected dimorphism in HLA B*44 alters self, peptide reportoire and T cell recognition.'''<br />
'''A natural selected dimorphism in HLA B*44 alters self, peptide reportoire and T cell recognition.'''<br />
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1N2R is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ACY as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1N2R OCA].
+
1N2R is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ACY:'>ACY</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1N2R OCA].
==Reference==
==Reference==
Line 36: Line 35:
[[Category: signal]]
[[Category: signal]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:17:11 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:26:49 2008''

Revision as of 14:26, 15 February 2008


1n2r, resolution 1.7Å

Drag the structure with the mouse to rotate

A natural selected dimorphism in HLA B*44 alters self, peptide reportoire and T cell recognition.

Contents

Overview

HLA-B*4402 and B*4403 are naturally occurring MHC class I alleles that are, both found at a high frequency in all human populations, and yet they only, differ by one residue on the alpha2 helix (B*4402 Asp156-->B*4403 Leu156)., CTLs discriminate between HLA-B*4402 and B*4403, and these allotypes, stimulate strong mutual allogeneic responses reflecting their known, barrier to hemopoeitic stem cell transplantation. Although HLA-B*4402 and, B*4403 share >95% of their peptide repertoire, B*4403 presents more unique, peptides than B*4402, consistent with the stronger T cell alloreactivity, observed toward B*4403 compared with B*4402. Crystal structures of B*4402, and B*4403 show how the polymorphism at position 156 is completely buried, and yet alters both the peptide and the heavy chain conformation, relaxing, ligand selection by B*4403 compared with B*4402. Thus, the polymorphism, between HLA-B*4402 and B*4403 modifies both peptide repertoire and T cell, recognition, and is reflected in the paradoxically powerful alloreactivity, that occurs across this "minimal" mismatch. The findings suggest that, these closely related class I genes are maintained in diverse human, populations through their differential impact on the selection of peptide, ligands and the T cell repertoire.

Disease

Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[142830], Hypoproteinemia, hypercatabolic OMIM:[109700], Spondyloarthropathy, susceptibility to, 1 OMIM:[142830], Stevens-Johnson syndrome, carbamazepine-induced, susceptibility to OMIM:[142830]

About this Structure

1N2R is a Protein complex structure of sequences from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition., Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, Gorman JJ, Clements CS, Kjer-Nielsen L, Koelle DM, Burrows SR, Tait BD, Holdsworth R, Brooks AG, Lovrecz GO, Lu L, Rossjohn J, McCluskey J, J Exp Med. 2003 Sep 1;198(5):679-91. Epub 2003 Aug 25. PMID:12939341

Page seeded by OCA on Fri Feb 15 16:26:49 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools